Long-Term Outcomes of 125 Patients With Metastatic Pheochromocytoma or Paraganglioma Treated With 131-I MIBG

Abstract Context Prognosis of metastatic pheochromocytoma/paraganglioma following 131-Iodine metaiodobenzylguanidine (MIBG) is incompletely characterized due to small samples and shorter follow-up in these rare, often indolent tumors. Objective To describe long-term survival, frequency, and prognost...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The journal of clinical endocrinology and metabolism 2020-03, Vol.105 (3), p.e494-e501
Hauptverfasser:	Thorpe, Matthew P, Kane, Ari, Zhu, Jason, Morse, Michael A, Wong, Terence, Borges-Neto, Salvador
Format:	Artikel
Sprache:	eng
Schlagworte:	3-Iodobenzylguanidine - therapeutic use Adrenal Gland Neoplasms - radiotherapy Adrenal Gland Neoplasms - secondary Adult Catecholamines Clinical s Disease Progression Female Follow-Up Studies Humans Iodine Iodine Radioisotopes - therapeutic use Laboratories Male Medical prognosis Metastases Metastasis Middle Aged Neuroendocrine tumors Paraganglioma Paraganglioma - pathology Paraganglioma - radiotherapy Pheochromocytoma Pheochromocytoma - pathology Pheochromocytoma - radiotherapy Prognosis Radiopharmaceuticals - therapeutic use Retrospective Studies Solid tumors Survival Survival Rate
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!